Factors in Treatment Decisions in Acute Myeloid Leukemia
Topic Areas:
Acute Myeloid Leukemia
View next
Published on May 16, 2016
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 February to 27 February 2016, Christoph Röllig, MD, from the University Hospital Carl Gustav Carus, Dresden, Germany, explains the different therapeutic needs of younger and older patients with acute myeloid leukemia.
This programme has been supported by Pfizer, through an unrestricted educational grant to the Patient Empowerment Foundation
